Toxoplasma gondii is capable of exogenous folate transport -: A likely expansion of the BT1 family of transmembrane proteins

被引:32
作者
Massimine, KM
Doan, LT
Atreya, CA
Stedman, TT
Anderson, KS
Joiner, KA
Coppens, I
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA
基金
英国惠康基金;
关键词
Apicomplexa; intracellular parasitism; BT1; membrane transporter; folate metabolism; folic acid;
D O I
10.1016/j.molbiopara.2005.07.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Folates are key elements in eukaryotic biosynthetic processes. The protozoan parasite Toxoplasma gondii possesses the enzymes necessary for de novo folate synthesis and has been suggested to lack alternative mechanisms for folate acquisition. In this paper, we present a different view by providing evidence that Toxoplasma is capable of salvaging exogenous folates. By monitoring uptake of radiolabeled folates by parasites in axenic conditions, our studies revealed a common folate transporter that has a high affinity for folic, acid. Transport of this compound across the parasite plasma membrane is rapid, biphasic, temperature dependent, bi-directional, concentration dependent and specific. In addition, morphological evidence demonstrates that fluorescent methottexate, a folate analog, is internalized by Toxoplasma and shows localization reminiscent to the mitochondrion. The presence of putative folate transporter genes in the Toxoplasma genome, which are homologous to the BT1 family of proteins, suggests that Toxoplasma may encode proteins involved in folate transport. Interestingly, genome analysis suggests that the BT1 family of proteins exists not only in Toxoplasma, but in other Apicomplexan parasites as well. Altogether, our results not only have implications for current therapeutic regimens against T gondii, but they also allude that the folate transport mechanism may represent a novel Apicomplexan target for the development of new drugs. (D 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 45 条
[11]  
Derouin F, 2001, Curr Opin Investig Drugs, V2, P1368
[12]  
ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053
[13]   Some aspects of protozoan infections in immunocompromised patients - A review [J].
Ferreira, MS ;
Borges, AS .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (04) :443-457
[14]  
HENDERSON GB, 1984, J BIOL CHEM, V259, P1526
[15]   Toxoplasma gondii:: transmission, diagnosis and prevention [J].
Hill, D ;
Dubey, JP .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (10) :634-640
[16]   Transport of methotrexate into PC-3 human prostate cancer cells [J].
Horne, DW ;
Reed, KA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 394 (01) :39-44
[17]  
JANSEN G, 1990, J BIOL CHEM, V265, P18272
[18]   Validation of the hexose transporter of Plasmodium falciparum as a novel drug target [J].
Joët, T ;
Eckstein-Ludwig, U ;
Morin, C ;
Krishna, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7476-7479
[19]   Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells [J].
Jolivet, J ;
Faure, MP ;
Wong, SC ;
Taub, JW ;
Matherly, LH .
BRITISH JOURNAL OF CANCER, 1997, 76 (06) :734-738
[20]   POTENT EFFECT OF TRIMETREXATE, A LIPID-SOLUBLE ANTIFOLATE, ON TOXOPLASMA-GONDII [J].
KOVACS, JA ;
ALLEGRA, CJ ;
CHABNER, BA ;
SWAN, JC ;
DRAKE, J ;
LUNDE, M ;
PARRILLO, JE ;
MASUR, H .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :1027-1032